25.06 USD
▲+0.25+8.91%
盘后 22.94 -0.30%
2026-08-03
市值
$2.84B
市盈率
—
EPS
-2.35
股息率
—
52 周区间
8.67 – 27.65
成交量
1.80M
Beta
2.07
目标价
35.77
52W 低 8.6752W 高 27.65
价格走势
公司简介
Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including I...